On Dec. 16, 2020, Aphria (APHA) and Tilray (TLRY) announced a merger that has created the world’s largest cannabis company. Both stocks jumped after the announcement as markets welcomed consolidation in an industry marred by perennial losses. Many investors are now wondering what happened to Aphria and Tilray stocks after the merger.
Full Answer
Why is Aphria stock falling hard today?
Apr 08, 2022 · Why Tilray Stock Skyrocketed 54% Last Week - The Motley Fool Canada fool.ca - March 28 at 4:53 PM Global $80 Billion Cannabis Products Markets, 2016-2021, 2021-2026F, 2031F by Products, Usage, Compound, & Route - ResearchAndMarkets.com - Business Wire
How can I get the latest news about APHA?
Apr 15, 2021 · However, it appears momentum is on the downside right now. Since hitting its 52-week high of more than $32 per share, investors can now pick up APHA stock at a 50% discount. This may seem like an ...
How much should Aphria stock have traded at before the merger?
Feb 17, 2021 · As of 3 p.m. EST, Aphria's stock price was up more than 25%. So what Cantor Fitzgerald analyst Pablo Zuanic reiterated his overweight rating on Aphria's shares and boosted his one-year price...
Is Aphria’s strategy working?
Jun 03, 2021 · On Dec. 16, 2020, Aphria (APHA) and Tilray (TLRY) announced a merger that has created the world’s largest cannabis company. Both stocks jumped after the announcement as markets welcomed...
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.Mar 11, 2021
What is the prediction for APHA stock?
Aphria Inc quote is equal to 17.230 USD at 2022-02-23. Based on our forecasts, a long-term increase is expected, the "APHA" stock price prognosis for 2026-07-01 is 58.128 USD. With a 5-year investment, the revenue is expected to be around +237.36%. Your current $100 investment may be up to $337.36 in 2027.
Should I sell my APHA stock?
Aphria Inc(APHA-T) Rating Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Will APHA stock turn into TLRY?
The company will continue to trade on the Nasdaq Global Select Exchange under the symbol "TLRY" and will commence trading on the Toronto Stock Exchange under the symbol "TLRY" on May 5. Under the terms, Aphria shareholders receive 0.8381 of a Tilray share for each common share of Aphria.May 3, 2021
Will Tilray go up?
That means that it is possible for Tilray to reach $4 billion in 2024 if its trajectory continues as it has. In other words, it doubles in 2022 to reach $1 billion in revenue. That $1 doubles again in 2023, reaching $2 billion, and then again in 2024 to hit the stated $4 billion goal.Jan 4, 2022
What is the future of HEXO?
HEXO is a market leader in the Canadian cannabis market and is expected to increase sales by 84% to $227.66 million in fiscal 2022 and by 31% to $298 million in fiscal 2023. Bay Street also expects its loss per share to narrow from $0.89 in 2021 to $0.22 in 2023.Dec 23, 2021
What happens to APHA shares after merger?
After Aphria and Tilray merge, the combined entity will be called Tilray and the shares will continue to trade on Nasdaq under the ticker TLRY. Yet the terms of the deal look more advantageous to Aphria. First of all, the company's CEO and chairman, Irwin Simon, will remain at the helm.Mar 22, 2021
Did Tilray acquire Aphria?
Tilray-Aphria merger closes, expanded company to control biggest share of Canadian pot market. Canadian cannabis companies Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.May 3, 2021
What will happen to APHA stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
What did APHA become?
Tilray and Aphria Close Cannabis Merger Tilray (TLRY) - Get Tilray Brands, Inc. Report and Aphria (APHA) - Get Aphria Inc Report said Monday they had completed their merger, creating the world's largest cannabis company by revenue.May 3, 2021
Valuation Problematic for APHA Stock
The valuation of most cannabis producers has always been a problem for me.
Conclusion
In addition to the valuation concerns, another issue I have with Aphria right now is the lack of U.S. exposure.
Analysts are excited about the cannabis company's upcoming merger with Tilray
Joe honed his investing skills as an analyst for Stock Advisor, Supernova, and Fool One. He battle-tested his investment philosophy and strategies as portfolio manager of Tier 1, a market-crushing Motley Fool real-money portfolio that delivered 24.58% annualized returns during its existence.
What happened
Shares of Aphria ( NASDAQ:APHA) surged on Tuesday, following bullish analyst commentary. As of 3 p.m. EST, Aphria's stock price was up more than 25%.
So what
Cantor Fitzgerald analyst Pablo Zuanic reiterated his overweight rating on Aphria's shares and boosted his one-year price forecast from $20.50 to $25.62. Zuanic's new target is roughly 51% higher than Aphria's closing price on Friday and 20% above its current price near $21.30.
Now what
The pending union of Aphria and Tilray is intriguing. The prospective cannabis titan would not only have a leading market share in Canada, but also strong growth prospects in international markets.
What is the ticker symbol for Tilray?
After the merger completion, the new entity trades under Tilray’s ticker symbol, “TLRY” on both the US and Canadian stock exchanges. In a press release, Tilray said that the combined entity had proforma revenue of $685 million in the last year.
Is Aphria a Tilray?
Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. The merger had got delayed due to the delay in approval from Tilray shareholders.
The cannabis company could deliver sizable gains to investors, according to one analyst
Joe honed his investing skills as an analyst for Stock Advisor, Supernova, and Fool One. He battle-tested his investment philosophy and strategies as portfolio manager of Tier 1, a market-crushing Motley Fool real-money portfolio that delivered 24.58% annualized returns during its existence.
What happened
Shares of Aphria ( NASDAQ:APHA) popped 12.3% on Monday, following bullish analyst comments.
So what
Cantor Fitzgerald analyst Pablo Zuanic named Aphria his top pick among Canadian cannabis stocks. He also boosted his price forecast from $7.86 to $8.23. Zuanic's new target price represents potential gains for investors of more than 40%, based on Aphria's closing stock price of $5.74.
Now what
Analysts are becoming more bullish on the cannabis industry's growth prospects, with some going so far as to predict that the U.S. could legalize marijuana at the federal level as early as 2021 should former Vice President Joe Biden win the presidential election in November and the Democrats gain control of Congress.
XPeng Inc - ADR Stock Forecast, "XPEV" Share Price Prediction Charts
mayris1st — I don't understand, why NIO it is not in the US Forecast but you do have Xpeng?
Brightstar Resources Stock Forecast, "SHK" Share Price Prediction Charts
allwynrego_7583 — Can you please get this company data updated. It is displaying error when you click the button Generate 7 days forecast. The company code has...
Texas Gulf Energy Stock Forecast, "TXGE" Share Price Prediction Charts
Term Box: Best Alpha Lithium Corporation forecast, APHLF stock price prediction, APHLF forecast, Alpha Lithium Corporation finance tips, APHLF prediction, Alpha Lithium Corporation analyst report, APHLF stock price predictions 2021, Alpha Lithium Corporation stock forecast, APHLF forecast tomorrow, Alpha Lithium Corporation technical analysis, APHLF stock future price, Alpha Lithium Corporation projections, Alpha Lithium Corporation market prognosis, APHLF expected stock price..
Aphria is benefiting from Aurora Cannabis's most recent earnings report
A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.
What happened?
Aphria ( NASDAQ:APHA) ended the week on a strong note. Shares of the Ontario-based cannabis company climbed by 11.3% on Friday, despite the company not reporting any news.
So what
There was little hope that Aurora Cannabis would be able to deliver strong financial results, especially after Tilray ( NASDAQ:TLRY) -- another big player in the marijuana industry -- disappointed with its own earnings report.
Now what
For its part, Aphria has consistently delivered strong financial results of late, especially when compared to its peers in the cannabis industry. For instance, in its most recent quarterly update, the company recorded a net revenue of 144.4 million Canadian dollars, a 19.8% sequential increase.
Sequential revenue declines
Revenue in the quarter increased 849% versus last year, but declined 2% sequentially. This is a dramatic slowing of revenue and is a cause for concern. Although the company experienced a fire at its British Columbia facility, which explains this somewhat, it’s still a dramatic slowing.
Non-operating income drives Aphria to net profit
Driving down further on the income statement, we can see that adjusted EBITDA of $1 million is climbing higher as “cost containment strategies were employed across the business. While net income was positive in the quarter, if we take out non-operating income, the net earnings are wiped out and turn into a net loss.
Entering the significant and expanding German medical cannabis market
The German medical cannabis market is growing — and growing rapidly. During the first half of 2019, Germany imported an estimated almost 2,500 kilograms of medical cannabis for pharmacy dispensing, which is almost as much as imports in the full year of 2018.
Taking it slow in the U.S
With too much uncertainty with regard to ultimate legalization in the U.S., Aphria will continue to take it slowly there. Management continues to have discussions with potential partners in order to be aware of strategic opportunities and positioned to enter whenever the U.S. market is conducive to it.
Foolish bottom line
Looking ahead, management is still confident in their net revenue guidance of $650 million to $700 million and EBITDA of $88 to $95 million in fiscal 2020. This compares to net revenue of $237 million in fiscal 2019, and represents an approximately 185% increase.